Detection of human papillomavirus infection and p16 immunohistochemistry expression in bladder cancer with squamous differentiation

PLoS ONE

Volumn 9, Issue 3, 2014, Pages

  Kim, Sung Han ^a   Joung, Jae Young ^a   Chung, Jinsoo ^a   Park, Weon Seo ^a   Lee, Kang Hyun ^a   Seo, Ho Kyung ^a  

^a National Cancer Center   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P16; VIRUS DNA;

AGED; ARTICLE; BLADDER CANCER; CELL DIFFERENTIATION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ETHNIC GROUP; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KOREAN; MALE; PAPILLOMAVIRUS INFECTION; PROTEIN EXPRESSION; SMOKING; SQUAMOUS CELL; SQUAMOUS CELL METAPLASIA; TRANSITIONAL CELL CARCINOMA; BLADDER; CARCINOMA, SQUAMOUS CELL; GENE EXPRESSION; GENETICS; HUMAN PAPILLOMAVIRUS TYPE 16; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; PATHOLOGY; URINARY BLADDER NEOPLASMS; VIROLOGY;

AGED; CARCINOMA, SQUAMOUS CELL; CELL DIFFERENTIATION; DNA, VIRAL; FEMALE; GENE EXPRESSION; HUMAN PAPILLOMAVIRUS 16; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; URINARY BLADDER; URINARY BLADDER NEOPLASMS;

EID: 84899828930     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0093525     Document Type: Article

References (38)

1. Grignon DJ, El-Bolkainy MN, Schmitz-Drager BJ, Simon R, Tyoznski JE (2004) Squamous cell carcinoma; Eble JN SG, Epstein JI, Sesterhenn IA, editor. Lyon,France: IARC Press. 3 p.
2. Freedman ND, Silverman DT, Hollenbeck AR, Schatzkin A, Abnet CC (2011) Association between smoking and risk of bladder cancer among men and women. JAMA 306: 737-745.
3. Silverman DT, Hartge P, Morrison AS, Devesa SS (1992) Epidemiology of bladder cancer. Hematol Oncol Clin North Am 6: 1-30.
4. Parkin DM, Bray F (2006) Chapter 2: The burden of HPV-related cancers. Vaccine 24 Suppl 3: S3/11-25.
5. Blochin EB, Park KJ, Tickoo SK, Reuter VE, Al-Ahmadie H (2012) Urothelial carcinoma with prominent squamous differentiation in the setting of neurogenic bladder: role of human papillomavirus infection. Mod Pathol 25: 1534-1542.
6. Shigehara K, Sasagawa T, Doorbar J, Kawaguchi S, Kobori Y, et al. (2011) Etiological role of human papillomavirus infection for inverted papilloma of the bladder. J Med Virol 83: 277-285.
7. zur Hausen H (2009) Papillomaviruses in the causation of human cancers - a brief historical account. Virology 384: 260-265.
8. Agliano AM, Gazzaniga P, Cervigni M, Gradilone A, Napolitano M, et al. (1994) Detection of human papillomavirus type 16 DNA sequences in paraffin-embedded tissues from the female urinary tract. Urol Int 52: 208-212. (Pubitemid 24132979)
9. Badawi H, Ahmed H, Ismail A, Diab M, Moubarak M, et al. (2008) Role of human papillomavirus types 16, 18, and 52 in recurrent cystitis and urinary bladder cancer among Egyptian patients. Medscape J Med 10: 232.
10. Alexander RE, Hu Y, Kum JB, Montironi R, Lopez-Beltran A, et al. (2012) p16 expression is not associated with human papillomavirus in urinary bladder squamous cell carcinoma. Mod Pathol 25: 1526-1533.
11. Moonen PM, Bakkers JM, Kiemeney LA, Schalken JA, Melchers WJ, et al. (2007) Human papilloma virus DNA and p53 mutation analysis on bladder washes in relation to clinical outcome of bladder cancer. Eur Urol 52: 464-468.
12. Helal Tel A, Fadel MT, El-Sayed NK (2006) Human papilloma virus and p53 expression in bladder cancer in Egypt: relationship to schistosomiasis and clinicopathologic factors. Pathol Oncol Res 12: 173-178. (Pubitemid 44719645)
13. Gutierrez J, Jimenez A, de Dios Luna J, Soto MJ, Sorlozano A (2006) Meta-analysis of studies analyzing the relationship between bladder cancer and infection by human papillomavirus. J Urol 176: 2474-2481; discussion 2481.
14. Cai T, Mazzoli S, Mondaini N, Bartoletti R (2008) Re: Paula M.J. Moonen, Judith M.J.E. . Bakkers, Lambertus A.L.M. . Kiemenay, et al. Human papilloma virus DNA and p53 mutation analysis on bladder washes in relation to clinical outcome of bladder cancer. Eur Urol 2007;52:464-9. Eur Urol 53: 858-859; author reply 859.
15. Polesel J, Gheit T, Talamini R, Shahzad N, Lenardon O, et al. (2012) Urinary human polyomavirus and papillomavirus infection and bladder cancer risk. Br J Cancer 106: 222-226.
16. Li Y, Nichols MA, Shay JW, Xiong Y (1994) Transcriptional repression of the D-type cyclin-dependent kinase inhibitor p16 by the retinoblastoma susceptibility gene product pRb. Cancer Res 54: 6078-6082. (Pubitemid 24378633)
17. Shaker OG, Hammam OA, Wishahi MM (2013) Is there a correlation between HPV and urinary bladder carcinoma? Biomed Pharmacother 67: 183-191.
18. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, et al. (1999) Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189: 12-19. (Pubitemid 29406813)
19. Abol-Enein H (2008) Infection: is it a cause of bladder cancer? Scand J Urol Nephrol Suppl: 79-84.
20. Choi YD, Jung WW, Nam JH, Choi HS, Park CS (2005) Detection of HPV genotypes in cervical lesions by the HPV DNA Chip and sequencing. Gynecol Oncol 98: 369-375.
21. Youshya S, Purdie K, Breuer J, Proby C, Sheaf MT, et al. (2005) Does human papillomavirus play a role in the development of bladder transitional cell carcinoma? A comparison of PCR and immunohistochemical analysis. J Clin Pathol 58: 207-210. (Pubitemid 40193809)
22. Wiwanitkit V (2005) Urinary bladder carcinoma and human papilloma virus infection, an appraisal of risk. Asian Pac J Cancer Prev 6: 217-218.
23. Khaled HM, Raafat A, Mokhtar N, Zekri AR, Gaballah H (2001) Human papilloma virus infection and overexpression of p53 protein in bilharzial bladder cancer. Tumori 87: 256-261. (Pubitemid 32928846)
24. Lopez-Beltran A, Escudero AL (1997) Human papillomavirus and bladder cancer. Biomed Pharmacother 51: 252-257. (Pubitemid 27296836)
25. Jimenez-Pacheco A, Exposito-Ruiz M, Arrabal-Polo MA, Lopez-Luque AJ (2012) Meta-analysis of studies analyzing the role of human papillomavirus in the development of bladder carcinoma. Korean J Urol 53: 240-247.
26. Steinestel J, Cronauer MV, Muller J, Al Ghazal A, Skowronek P, et al. (2013) Overexpression of p16(INK4a) in Urothelial Carcinoma In Situ Is a Marker for MAPK-Mediated Epithelial-Mesenchymal Transition but Is Not Related to Human Papillomavirus Infection. PLoS One 8: e65189.
27. Sano T, Sakurai S, Fukuda T, Nakajima T (1995) Unsuccessful effort to detect human papillomavirus DNA in urinary bladder cancers by the polymerase chain reaction and in situ hybridization. Pathol Int 45: 506-512.
28. Um TH, Lee EH, Chi HS, Kim JW, Hong YJ, et al. (2011) Comparison of HPV genotyping assays and Hybrid Capture 2 for detection of high-risk HPV in cervical specimens. Ann Clin Lab Sci 41: 48-55.
29. Kim CJ, Jeong JK, Park M, Park TS, Park TC, et al. (2003) HPV oligonucleotide microarray-based detection of HPV genotypes in cervical neoplastic lesions. Gynecol Oncol 89: 210-217. (Pubitemid 36457867)
30. Anwar K, Naiki H, Nakakuki K, Inuzuka M (1992) High frequency of human papillomavirus infection in carcinoma of the urinary bladder. Cancer 70: 1967-1973.
31. Boucher NR, Anderson JB (1997) Human papillomavirus and bladder cancer. Int Urogynecol J Pelvic Floor Dysfunct 8: 354-357. (Pubitemid 28203927)
32. Cai T, Mazzoli S, Meacci F, Nesi G, Geppetti P, et al. (2011) Human papillomavirus and non-muscle invasive urothelial bladder cancer: potential relationship from a pilot study. Oncol Rep 25: 485-489.
33. Lehoux M, D'Abramo CM, Archambault J (2009) Molecular mechanisms of human papillomavirus-induced carcinogenesis. Public Health Genomics 12: 268-280.
34. Buitrago-Perez A, Garaulet G, Vazquez-Carballo A, Paramio JM, Garcia-Escudero R (2009) Molecular Signature of HPV-Induced Carcinogenesis: pRb, p53 and Gene Expression Profiling. Curr Genomics 10: 26-34.
35. Scheffner M, Werness BA, Huibregtse JM, Levine AJ, Howley PM (1990) The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 63: 1129-1136. (Pubitemid 120035062)
36. Chen Z, Schiffman M, Herrero R, Desalle R, Anastos K, et al. (2011) Evolution and taxonomic classification of human papillomavirus 16 (HPV16)-related variant genomes: HPV31, HPV33, HPV35, HPV52, HPV58 and HPV67. PLoS One 6: e20183.
37. Doxtader EE, Katzenstein AL (2012) The relationship between p16 expression and high-risk human papillomavirus infection in squamous cell carcinomas from sites other than uterine cervix: a study of 137 cases. Hum Pathol 43: 327-332.
38. Bussu F, Sali M, Gallus R, Vellone VG, Zannoni GF, et al. (2013) HPV infection in squamous cell carcinomas arising from different mucosal sites of the head and neck region. Is p16 immunohistochemistry a reliable surrogate marker? Br J Cancer 108: 1157-1162.